Follow
Measurable Residual Disease AML
Measurable residual disease (MRD) is a prognostic indicator used to assess the severity and risk associated with cases of acute myeloid leukemia (AML). MRD is determined after AML diagnosis and helps doctors and patients with disease management and treatment planning.
